oleic acid has been researched along with Kidney Diseases in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (28.57) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (71.43) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
An, WS; Kim, SE; Lee, MH; Lee, SM; Park, Y; Rha, SH; Son, YK | 1 |
Du, Y; Guan, G; Jia, Z; Ling, H; Liu, S; Liu, Y; Yang, T; Zhang, A; Zhou, L; Zhou, SF | 1 |
Wang, H; Zhao, Y | 1 |
Abe, M; Abe, T; Akiyama, Y; Ito, S; Moriguchi, T; Sato, H; Shibata, E; Souma, T; Suzuki, T; Takai, J; Tanemoto, M; Toyohara, T; Yamamoto, M; Yanagisawa-Miyazawa, N | 1 |
Bačiak, L; Beňo, M; Bilaničová, D; Boor, P; Celec, P; Dušinská, M; Hodosy, J; Kebis, A; Kollárová, R; Marcomini, A; Pojana, G; Príbojová, J; Šebeková, K; Simon Klenovics, K; Staruchová, M; Tulinská, J; Tušková, R; Vlková, B; Volkovová, K | 1 |
Bounaud, JY; Bounaud, MP; Jallet, P; Perdrisot, R | 1 |
Fukushima, S; Ito, N; Kurata, Y; Ogiso, T; Shibata, M; Tamano, S | 1 |
7 other study(ies) available for oleic acid and Kidney Diseases
Article | Year |
---|---|
Omega-3 fatty acid decreases oleic acid by decreasing SCD-1 expression in the liver and kidney of a cyclosporine-induced nephropathy rat model.
Topics: Acetyltransferases; Animals; Cell Membrane; Cyclosporine; Dietary Supplements; Disease Models, Animal; Erythrocytes; Fatty Acid Elongases; Fatty Acids, Omega-3; Kidney; Kidney Diseases; Lipid Metabolism; Liver; Male; Oleic Acid; Rats; Rats, Sprague-Dawley; Stearoyl-CoA Desaturase | 2019 |
Nitro-oleic acid protects against adriamycin-induced nephropathy in mice.
Topics: Animals; Blood Urea Nitrogen; Disease Models, Animal; Doxorubicin; Kidney Diseases; Kidney Glomerulus; Male; Mice; Mice, Inbred BALB C; Oleic Acid | 2013 |
[Activation of SUR2B/Kir6.1-type K(ATP) channels protects glomerular endothelial, mesangial and tubular epithelial cells against oleic acid renal damage].
Topics: Cells, Cultured; Epithelial Cells; Glyburide; Humans; KATP Channels; Kidney; Kidney Diseases; Oleic Acid; Propylamines; Protective Agents | 2012 |
Luminal alkalinization attenuates proteinuria-induced oxidative damage in proximal tubular cells.
Topics: Albumins; Animals; Apoptosis; Cell Line; Disease Models, Animal; Disease Progression; DNA Damage; Female; Focal Adhesion Kinase 2; Humans; Hydrogen-Ion Concentration; Kidney Diseases; Kidney Tubules, Proximal; Male; Mice; Mice, Inbred C57BL; NADPH Oxidases; Oleic Acid; Oxidative Stress; Oxygen; Proteinuria; Reactive Oxygen Species; Sodium Bicarbonate | 2011 |
Comprehensive assessment of nephrotoxicity of intravenously administered sodium-oleate-coated ultra-small superparamagnetic iron oxide (USPIO) and titanium dioxide (TiO2) nanoparticles in rats.
Topics: Animals; Female; Fibrosis; Inflammation; Kidney; Kidney Diseases; Lethal Dose 50; Magnetic Resonance Spectroscopy; Magnetite Nanoparticles; Metal Nanoparticles; Oleic Acid; Oxidative Stress; Rats; Rats, Wistar; Titanium; Tumor Necrosis Factor-alpha | 2014 |
Four nonisotopic immunoassays of free thyroxin evaluated.
Topics: Albumins; Autoantibodies; Critical Care; Female; Heparin; Humans; Hyperthyroidism; Hypothyroidism; Immunoassay; Kidney Diseases; Oleic Acid; Oleic Acids; Pregnancy; Quality Control; Radioimmunoassay; Reagent Kits, Diagnostic; Reference Values; Renal Dialysis; Thyroxine | 1989 |
13-week subchronic toxicity study with morpholine oleic acid salt administered to B6C3F1 mice.
Topics: Animals; Body Weight; Dose-Response Relationship, Drug; Female; Kidney; Kidney Diseases; Male; Mice; Morpholines; Oleic Acid; Oleic Acids; Organ Size | 1987 |